Last reviewed · How we verify

NCT05784116: PPDINFLAME

Immune/Inflammatory Biomarkers in Postpartum Depression

Status unknown Last updated 24 March 2023
What this trial tests

trial in Depression, Postpartum in 300 participants. Status unknown.

Timeline
1 April 2022
Primary endpoint
24 November 2024
24 November 2024

Quick facts

Lead sponsorIRCCS San Raffaele
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment300
Start date1 April 2022
Primary completion24 November 2024
Estimated completion24 November 2024
Sites1 location across Italy

Conditions studied

Sponsor

IRCCS San Raffaele — full company profile →

Who can join

Adults 18 to 45, female only, with Depression, Postpartum. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This will be a very straightforward study assessing changes of immune/inflammatory peripheral biomarkers before/after delivery with postpartum mood and the psychopathological features of postpartum depression (PPD), and with MRI measures of functional and structural brain integrity. Multimodal assessment of peripheral cytokines, PBMC gene expression, FACS immunophenotyping, and IDO activation, will be validated with (a) clinical data about the presentation of PPD, (b) self- and observer ratings of psychopatology, (c) results coming from neuropsychological assessment of cognitive functions, and (d) multimodal brain imaging outcomes (WM integrity, functional connectivity, GM volumes). It is expected that worsening or stabilization of mood, and the diagnosis of PPD, will be paralleled by worsening or stabilization of these measures, thus providing new markers to estimate the susceptibility to the disorder, to identify targets for treatment, and to predict and monitor treatment efficacy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Depression, Postpartum

Currently open trials in the same condition.

Other IRCCS San Raffaele trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05784116.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing